Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review-Reference-Cited by-同舟云学术

Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review

Published:2021-06 Issue:6 Volume:205 Page:1569-1576
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Chakiryan Nicholas H.¹^ORCID,Dahmen Aaron²,Cucchiara Vito³,Briganti Alberto³⁴,Montorsi Francesco³⁴,Salonia Andrea³⁴,Spiess Philippe E.¹,Necchi Andrea³⁴

Affiliation:

1. Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida

2. Department of Urology, University of South Florida, Tampa, Florida

3. Department of Urology, IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy

4. Vita-Salute San Raffaele University, Milan, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rhabdomyosarcoma in Adults: De Novo or Conversion From Non-seminomas?;Cureus;2024-03-03

2. Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study;Clinical Cancer Research;2023-11-15

3. Guideline of guidelines: follow‐up after orchidectomy for clinical stage 1 testicular cancer;BJU International;2023-07-18

4. Refining the serum miR-371a-3p test for viable germ cell tumor detection;Scientific Reports;2023-06-29

5. Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate range;2023-03-21